← Back
$NAMS All transactions

NewAmsterdam Pharma Co N.V.

A

$ Value

Shares

25,500

Price

Filed

Jan 7

Insider

Name

Kastelein Johannes Jacob Pieter

Title

Chief Scientific Officer

CIK

0002000389

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-07

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

98,981

Footnotes

Represents pre-arranged sale of shares by the Reporting Person solely to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) pursuant to sell-to-cover agreement entered into with the Issuer. The sale does not represent a discretionary transaction by the Reporting Person. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.77 to $33.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | Represents RSUs, each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date. | Each RSU was granted on January 7, 2026 for no consideration. | 25% of the shares underlying the option will vest on Janaury 2, 2027, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Filing Info

Accession No.

0001193125-26-006662

Form Type

4

Issuer CIK

0001936258

Kastelein Johannes Jacob Pieter's History

Date Ticker Type Value
2026-01-07 NAMS A
2026-01-07 NAMS A $0
2026-01-05 NAMS $200K
2025-08-22 NAMS $1.1M
2025-08-22 NAMS $195K
2025-08-21 NAMS $1.2M

Other Insiders at NAMS (90d)

Insider Bought Sold Last
Kooij Louise Frederika
Chief Accounting Officer
$4.8M 2026-01-28